Adjuvant Chemotherapy for Stage II Colon Cancer
In stage II colon cancer management, surgery alone has shown a high cure rate (about 80%), and the role of adjuvant chemotherapy is still a matter of debate. Patients with high-risk features (T4, insufficient nodal sampling, grading, etc.) have a poorer prognosis and, usually, adjuvant chemotherapy...
Main Authors: | Sara Elena Rebuzzi, Guido Pesola, Valentino Martelli, Alberto Felice Sobrero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2584 |
Similar Items
-
Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer
by: Yong Huang, et al.
Published: (2020-06-01) -
Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
by: Xin Chen, et al.
Published: (2022-06-01) -
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study
by: Leen Liao, et al.
Published: (2024-02-01) -
Survival of Resectable Stage II Colon Cancer Patients: Focus on Chemotherapy-Experience from a Single Institution
by: Hui-Wen Liu, et al.
Published: (2015-12-01) -
Differential impacts of clinical variables and 5-fluorouracil-based adjuvant chemotherapy on 5-year disease-free survival of patients with stage IIa and IIb colon cancer
by: Yi-Hung Kuo, et al.
Published: (2018-01-01)